Casadó-Anguera Verònica, Casadó Vicent
Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, and Institute of Biomedicine of the Universitat de Barcelona, Barcelona, Spain.
Laboratory of Neuropharmacology-Neurophar, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Expert Opin Drug Discov. 2022 Aug;17(8):897-923. doi: 10.1080/17460441.2022.2085684. Epub 2022 Jun 13.
Unexpected non-apparent and hidden allosteric-binding sites are non-classical and non-apparent allosteric centers in 3-D X-ray protein structures until orthosteric or allosteric ligands bind to them. The orthosteric center of one protomer that modulates binding centers of the other protomers within an oligomer is also an unexpected allosteric site. Furthermore, another partner protein can also produce these effects, acting as an unexpected allosteric modulator.
This review summarizes both classical and non-classical allosterism. The authors focus on G protein-coupled receptor (GPCR) oligomers as a paradigm of allosteric molecules. Moreover, they show several examples of unexpected allosteric sites such as hidden allosteric sites in a protomer that appear after the interaction with other molecules and the allosterism exerted between orthosteric sites within GPCR oligomer, emphasizing on the allosteric modulations that can occur between binding sites.
The study of these new non-classical allosteric sites will expand the diversity of allosteric control on the function of orthosteric sites within proteins, whether GPCRs or other receptors, enzymes, or transporters. Moreover, the design of new drugs targeting these hidden allosteric sites or already known orthosteric sites acting as allosteric sites in protein homo- or hetero-oligomers will increase the therapeutic potential of allosterism.
在正构或变构配体与其结合之前,意外的非表观和隐藏变构结合位点是三维X射线蛋白质结构中的非经典和非表观变构中心。寡聚体中一个原聚体的正构中心调节其他原聚体的结合中心,这也是一个意外的变构位点。此外,另一种伴侣蛋白也可产生这些效应,作为意外的变构调节剂。
本综述总结了经典和非经典变构作用。作者将G蛋白偶联受体(GPCR)寡聚体作为变构分子的范例进行重点阐述。此外,他们展示了几个意外变构位点的例子,如原聚体中与其他分子相互作用后出现的隐藏变构位点,以及GPCR寡聚体中正构位点之间产生的变构作用,着重介绍了结合位点之间可能发生的变构调节。
对这些新的非经典变构位点的研究将扩大对蛋白质(无论是GPCR还是其他受体、酶或转运蛋白)中正构位点功能变构控制的多样性。此外,针对这些隐藏变构位点或在蛋白质同型或异型寡聚体中作为变构位点的已知正构位点设计新药,将增加变构作用的治疗潜力。